Ranolazine can markedly increase tacrolimus blood levels

We report the case of a renal transplant patient on tacrolimus who developed a fully reversible renal failure and a doubling in serum tacrolimus closely associated with initiation of ranolazine (Ranexa) treatment, a new anti-angina drug recently introduced in Europe.

Detalles Bibliográficos
Autores principales: Seck, Sidy, Bellantoni, Marianna, Zoccali, Carmine, Enia, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421639/
https://www.ncbi.nlm.nih.gov/pubmed/25984101
http://dx.doi.org/10.1093/ndtplus/sfq180
_version_ 1782369915812970496
author Seck, Sidy
Bellantoni, Marianna
Zoccali, Carmine
Enia, Giuseppe
author_facet Seck, Sidy
Bellantoni, Marianna
Zoccali, Carmine
Enia, Giuseppe
author_sort Seck, Sidy
collection PubMed
description We report the case of a renal transplant patient on tacrolimus who developed a fully reversible renal failure and a doubling in serum tacrolimus closely associated with initiation of ranolazine (Ranexa) treatment, a new anti-angina drug recently introduced in Europe.
format Online
Article
Text
id pubmed-4421639
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44216392015-05-15 Ranolazine can markedly increase tacrolimus blood levels Seck, Sidy Bellantoni, Marianna Zoccali, Carmine Enia, Giuseppe NDT Plus Case Report We report the case of a renal transplant patient on tacrolimus who developed a fully reversible renal failure and a doubling in serum tacrolimus closely associated with initiation of ranolazine (Ranexa) treatment, a new anti-angina drug recently introduced in Europe. Oxford University Press 2011-02 2010-10-25 /pmc/articles/PMC4421639/ /pubmed/25984101 http://dx.doi.org/10.1093/ndtplus/sfq180 Text en © The Author 2010. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Seck, Sidy
Bellantoni, Marianna
Zoccali, Carmine
Enia, Giuseppe
Ranolazine can markedly increase tacrolimus blood levels
title Ranolazine can markedly increase tacrolimus blood levels
title_full Ranolazine can markedly increase tacrolimus blood levels
title_fullStr Ranolazine can markedly increase tacrolimus blood levels
title_full_unstemmed Ranolazine can markedly increase tacrolimus blood levels
title_short Ranolazine can markedly increase tacrolimus blood levels
title_sort ranolazine can markedly increase tacrolimus blood levels
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421639/
https://www.ncbi.nlm.nih.gov/pubmed/25984101
http://dx.doi.org/10.1093/ndtplus/sfq180
work_keys_str_mv AT secksidy ranolazinecanmarkedlyincreasetacrolimusbloodlevels
AT bellantonimarianna ranolazinecanmarkedlyincreasetacrolimusbloodlevels
AT zoccalicarmine ranolazinecanmarkedlyincreasetacrolimusbloodlevels
AT eniagiuseppe ranolazinecanmarkedlyincreasetacrolimusbloodlevels

Ejemplares similares